Ligand · WO9
WO9 · (2R)-3-{[(R)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(dodecanoyloxy)propyl heptadecanoate
WO9, (2R)-3-{[(R)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(dodecanoyloxy)propyl heptadecanoate (C34 H68 N O8 P, 649.9 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (2 PDB entries). Every binding site with its residues…
- Component
- WO9
- Formula
- C34 H68 N O8 P
- Class
- ligand
- Structures
- 2
- PDB entries
- 2
Binding sites
WO9 in 2 structures; the first of them:
- 8EOG · Structure of the human L-type voltage-gated calcium channel Cav1.2 complexed with… · WO9 K1705 · binds MET265, ALA272, VAL275, MET353, LEU354, PHE357, ILE360, THR361 and 9 more
- 8FD7 · Structure of the human L-type voltage-gated calcium channel Cav1.2 complexed with… · WO9 K1701 · binds MET265, LEU268, VAL275, ILE279, MET353, LEU354, PHE357, THR361 and 8 more
Residues it binds most
LEU 2, MET 2, PHE 2, ILE 2, THR 2, VAL 2, ASN 2, TYR 2, ALA 1 (residue and the binding sites it lines).
Found with
- CLR · Cholesterol
- CA · Calcium ion
- NA · Sodium ion
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose
- GBN · [1-(aminomethyl)cyclohexyl]acetic acid
- LEU · Leucine
- WNZ · (2R)-3-{[(R)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(dodecanoyloxy)propyl dodecanoate
- YSW · (2S)-3-{[(R)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(dodecanoyloxy)propyl dodecanoate
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.